Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders
article
OA: diamond
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study found serum HE4 levels were less elevated than CA125 in Chinese women with benign gynecologic disorders, suggesting HE4 is a more suitable biomarker.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: This study measured the human epididymis protein 4 (HE4) and CA125 levels in Chinese women with benign gynecological disorders. MATERIAL AND METHODS: Sera were obtained from Chinese women prior to surgery for a pelvic mass and HE4 and CA125 levels were determined. The proportions of patients with HE4 and CA125 levels were compared. RESULTS: There were 68 Chinese women with benign diseases. HE4 levels were less elevated than CA125 (1% V.S. 29%, P<0.001). The significant difference was observed in patients with endometriosis/endometriomas in which HE4 was not elevated patients and CA125 was elevated in 53% (P<0.001). Serum HE4 level was not elevated in patients with cystadenoma (0% V.S. 23%, P<0.001) and in patients with germ cell tumors (0% V.S. 5%, P<0.001). CONCLUSION: HE4 was less elevated and more suitable as a biomarker than CA125 in chinese women with benign disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer 2013
- Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women 2012
Cited by (1)
References (33)
- Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women via openalex
- The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer via openalex
- W1966868587 via openalex
- W1966945481 via openalex
- W1981559854 via openalex
- W1989868772 via openalex
- W2002081615 via openalex
- W2002852242 via openalex
- W2003877535 via openalex
- W2013111681 via openalex
- W2021271893 via openalex
- W2030493505 via openalex
- W2072755146 via openalex
- W2074453527 via openalex
- W2080345440 via openalex
- W2088152748 via openalex
- W2093252833 via openalex
- W2093282864 via openalex
- W2096904343 via openalex
- W2108250129 via openalex
- W2117275438 via openalex
- W2119642645 via openalex
- W2127936928 via openalex
- W2129355295 via openalex
- W2135884633 via openalex
- W2146711830 via openalex
- W2252412118 via openalex
- W2322793415 via openalex
- W2332608923 via openalex
- W2356474817 via openalex
- W1716576701 via openalex
- W4242463659 via openalex
- W1965927279 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:58.238279+00:00
License: CC0
· commercial use OK